RELEGARD- glacial acetic acid, oxyquinoline gel 
BLANSETT PHARMACAL CO

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

RELEGARD THERAPEUTIC VAGINAL GEL WITH APPLICATOR

DOSAGE AND ADMINISTRATION

TO OPEN: USE TOP OF CAP TO TWIST OFF SEAL.

FOR VAGINAL USE ONLY.

CONTAINS: GLACIAL ACETIC ACID 0.9%, OXYQUINOLINE 0.025%, PRESERVATIVE, GLYCERIN, LACTIC ACID BUFFER, POLYETHYLENE GLYCOL 4500 AND PURIFIED WATER. THE PH OF 3.8 - 4.3 IS ADJUSTED USING 1N POTASSIUM HYDROXIDE.

DO NOT USE IF TAMPER-RESISTANT SEAL AT OPENING HAS BEEN DISTURBED OR IS NOT VISIBLE. IF THIS SEAL HAS BEEN PUNCTURED OR IS NOT VISIBLE, RETURN PRODUCT TO PLACE OF PURCHASE.

STORE AT ROOM TEMPERATURE.

DO NOT TAKE BY MOUTH OR USE IN EYES.

COMPLETE PRESCRIBING INFORMATION IS ENCLOSED.

THIS BOX CONTAINS ONE APPLICATOR.

Relagard proof 7.25.02_Page_1

RELEGARD 
glacial acetic acid, oxyquinoline gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:51674-0130
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ACETIC ACID (UNII: Q40Q9N063P) (ACETIC ACID - UNII:Q40Q9N063P) ACETIC ACID0.9 mg  in 1 mL
OXYQUINOLINE (UNII: 5UTX5635HP) (OXYQUINOLINE - UNII:5UTX5635HP) OXYQUINOLINE0.025 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
LACTIC ACID (UNII: 33X04XA5AT)  
POLYETHYLENE GLYCOL 4500 (UNII: TVH7653921)  
WATER (UNII: 059QF0KO0R)  
POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51674-0130-550 mL in 1 TUBE; Type 0: Not a Combination Product03/20/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other03/20/2017
Labeler - BLANSETT PHARMACAL CO (037477378)
Establishment
NameAddressID/FEIBusiness Operations
BLANSETT PHARMACAL CO037477378manufacture(51674-0130)

Revised: 3/2017
Document Id: 85f9ed27-9fce-4cd5-9cb2-7dc9d6c06cb1
Set id: dd1b4ad8-08f2-4412-8a98-2d82ef35f053
Version: 1
Effective Time: 20170320
 
BLANSETT PHARMACAL CO